Expression of ALOX5 steadily increases with the progression of human Hepatocellular Carcinoma in HepG2 cells and- inhibition of ALOX5 via zileuton administration decreased cell viability and induced apoptosis in HepG2 cells [142]. This evidence concerns the gene ALOX5 and hepatocellular carcinoma.